These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1271550)

  • 1. Stress incontinence: conservative therapy with sympathomimetic drugs.
    Stewart BH; Banowsky LH; Montague DK
    J Urol; 1976 May; 115(5):558-9. PubMed ID: 1271550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence.
    Montague DK; Stewart BH
    J Urol; 1979 Aug; 122(2):198-9. PubMed ID: 37354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch.
    Scott L; Leddy M; Bernay F; Davot JL
    J Small Anim Pract; 2002 Nov; 43(11):493-6. PubMed ID: 12463265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
    Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
    Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women.
    Kinn AC; Lindskog M
    Urology; 1988 Sep; 32(3):273-80. PubMed ID: 3046105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence.
    Wein AJ
    J Urol; 1991 Dec; 146(6):1670-1. PubMed ID: 1942363
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenergic agents in urinary disorders of the proximal urethra. Part I. Sphincteric incontinence.
    Awad SA; Downie JW; Kiruluta HG
    Br J Urol; 1978 Aug; 50(5):332-5. PubMed ID: 37972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Wein AJ
    J Urol; 2005 Jun; 173(6):2056-7. PubMed ID: 15879827
    [No Abstract]   [Full Text] [Related]  

  • 10. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation.
    Fossberg E; Beisland HO; Lundgren RA
    Urol Int; 1983; 38(5):293-9. PubMed ID: 6685364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.
    Ek A; Andersson KE; Gullberg B; Ulmsten U
    Zentralbl Gynakol; 1980; 102(15):839-44. PubMed ID: 7006273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical approach to the management of urinary incontinence in the elderly.
    Diokno AC
    Compr Ther; 1983 Jul; 9(7):67-75. PubMed ID: 6883981
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary incontinence in castrated female dogs. 2. Therapy].
    Blendinger C; Blendinger K; Bostedt H
    Tierarztl Prax; 1995 Aug; 23(4):402-6. PubMed ID: 8578574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic drugs for urinary incontinence in adults.
    Alhasso A; Glazener CM; Pickard R; N'Dow J
    Cochrane Database Syst Rev; 2003; (2):CD001842. PubMed ID: 12804414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genuine stress incontinence: pathophysiology and rationale for its medical management.
    Fantl JA
    Obstet Gynecol Clin North Am; 1989 Dec; 16(4):827-40. PubMed ID: 2697817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
    Appell RA; Sand P; Dmochowski R; Anderson R; Zinner N; Lama D; Roach M; Miklos J; Saltzstein D; Boone T; Staskin DR; Albrecht D;
    Mayo Clin Proc; 2001 Apr; 76(4):358-63. PubMed ID: 11322350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A drug seeks its disease].
    Löfgren O
    Lakartidningen; 2010 Jun 2-8; 107(22):1488-9. PubMed ID: 20645604
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiotherapy of pelvic floor for incontinence].
    Galeri S; Sottini C
    Arch Ital Urol Androl; 2001 Sep; 73(3):143-6. PubMed ID: 11822057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The conservative treatment of stress incontinence in women with midodrine].
    Riccabona M
    Wien Klin Wochenschr; 1981 Mar; 93(5):163-5. PubMed ID: 6169204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phenylpropanolamine and pseudoephedrine on the urethral pressure profile and continence scores of incontinent female dogs.
    Byron JK; March PA; Chew DJ; DiBartola SP
    J Vet Intern Med; 2007; 21(1):47-53. PubMed ID: 17338149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.